25Oct/22
T Cells Expressing Alloimmune Defense Receptor (ADR) Show Promise in Preventing Graft-Versus-Host Disease and Cancer Recurrence
In a recent study, researchers from Baylor College of Medicine and Boston Children’s Hospital, among other institutions, genetically modified T cells to control two major life-threatening complications, graft-vs-host disease (GvHD) and cancerRead More…